Trinity Biotech (TRIB) Divestments (2023)
Trinity Biotech's (TRIB) quarterly Divestments came in at -$266000.0 in Q3 2023.
Analysis
Trinity Biotech (TRIB) Divestments (2023) Analysis & Trends
Trinity Biotech has disclosed Divestments across 1 years of filings, most recently posting -$266000.0 for Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.61 Bn | 27.50 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.10 Bn | 3.73 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.40 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | - |
| 6 | Ceribell | 924.56 Mn | 795.30 Mn | 25.94 Mn | - |
| 7 | QuidelOrtho | 876.63 Mn | 753.23 Mn | - | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | - |
| 9 | Prenetics Global | 341.11 Mn | 282.06 Mn | 30.20 Mn | - |
| 10 | Trinity Biotech | 5.34 Mn | 5.34 Mn | - | - |